Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases

Journal of Human Hypertension

Volumn 11, Issue 1, 1997, Pages 23-28

  Flack, J M ^a   Yunis, C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular diseases; Epidemiology; Myocardial; Target organ damage; Timing

Indexed keywords

BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CONFERENCE PAPER; DIABETES MELLITUS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; RISK FACTOR; SMOKING; STROKE; SUDDEN DEATH; THROMBOCYTE AGGREGATION;

EID: 0030889620     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000396     Document Type: Conference Paper

References (34)

1. MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-764.
2. Advance report of final mortality statistics, 1993. Monthly vital statistics report, 44 (7), Supplement 29 February 1996.
3. Mensah G, Liao Y, Cooper RS. Left ventricular hypertrophy as a risk factor in patients with or without coronary artery disease. Cardiovasc Risk Factors (in press).
4. Simmons BE et al. Survival determinants in black patients with angiographically defined coronary artery disease. Am Heart J 1990; 119: 513-519.
5. Sempos C, Cooper R, Kovar MG, McMillen M. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health 1988; 78: 1422-1427.
6. Wenneker MB, Epstein AM. Racial inequalities in the use of procedures with ischemic heart disease in Massachusetts. JAMA 1989; 261: 253-257.
7. Keil JE et al. Incidence of coronary heart disease in blacks in Charleston, South Carolina. Am Heart J1984; 108: 779-786.
8. Gillum RF, Liu KC. Coronary heart disease mortality in United States blacks, 1940-1978: trends and unanswered questions. Am Heart J 1984; 108: 728-732.
9. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26 year follow-up of the Framingham population. Am Heart J 1986; 111 (2): 383-390.
10. Burt VL et al. Trends in prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-69.
11. Flack JM, Neaton J, Daniels B, Esunge P. Ethnicity and renal disease: lessons from multiple risk factor intervention trial and treatment of mild hypertension study. Am J Kidney Dis 1993; 21 (4 Suppl I): 31-40.
12. Flack JM et al for the Multiple Risk Factor Intervention Trial Research Group. Blood pressure and mortality among men with prior myocardial infarction. Circulation 1995; 92: 2437-2445.
13. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971; 285: 1441-1446.
14. Kannel WB, Gordon T, Schwartz MJ. Systolic vs diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol 1971; 27: 335-346.
15. Italian Research Group of the Seven Countries Study. Incidence and prediction of coronary heart disease in two Italian rural population samples followed-up for 20 years. Acta Cardiol 1982; 37: 129-145.
16. Sutton-Tyrell K et al. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995; 26 (8): 1319-1324.
17. Anonymous. The effect of treatment on mortality in 'mild' hypertension: results of the Hypertension Detection and Follow-up program. N Engl J Med 1982; 307 (16): 976-980.
18. Collins R et al. Blood pressure, stroke, and coronary heart disease, Part 2; short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet 1990; 335: 827-838.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264.
20. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study (TOMHS): final results. JAMA 1993; 270: 713-724.
21. Cruickshank JM. Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction. Br Med J 1988; 297: 1227-1230.
22. Farnett L et al. The J-curve phenomenon and the treatment of hypertension. JAMA 1991; 265: 489-495.
23. Sutton-Tyrell K et al. Predictors of carotid stenosis in older adults with and without isolated systolic hypertension. Stroke 1993; 24 (3): 355-361.
24. Sutton-Tyrell K et al. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995; 26 (8): 1319-1324.
25. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79 (4): 733-743.
26. Asmar R et al. Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension. Am J Cardiol 1996; 77: 384-390.
27. Willich SN et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801-806.
28. Marler JR et al. Morning increase in onset of ischemic stroke. Stroke 1989; 20: 473-476.
29. Rocco MB, Nabel EG, Selwyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol 1987; 59: 13C-17C.
30. Rocco MB et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75: 395-400.
31. Villani A et al. Noninvasive automatic blood pressure monitoring does not attenuate nightime hypotension. Am J Hypertens 1992; 5: 744-747.
32. Khoury S, Yarows SA, O'Brien TK, Sowers JR. Ambulatory blood pressure monitoring in a nonacademic setting. Effects of age and sex. Am J Hypertens 1992; 5: 616-623.
33. Linsell CR et al. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 60: 1210-1215.
34. Brezinski DA et al. Morning increase in platelet aggregability. Circulation 1988; 78: 35-40.